{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:52:53Z","timestamp":1753883573059,"version":"3.41.2"},"reference-count":21,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We describe a case of an Asian-Indian female patient who presented to us with abnormal fat accumulations in the torso and upper arms following indiscriminate use of corticosteroid and anabolic steroids for about 7 years. Despite prolonged steroid use, the patient did not display cushingoid phenotype or metabolic decompensation. Bone density, echocardiography, and ultrasonogram of the liver were also normal with no evidence of excess pericardial fat, hepatic steatosis, or peliosis hepatis. Concurrent use of anabolic androgen is thought to be protective against the ill effects of steroids, especially on the muscle and bone. This phenomenon has been observed in children and adolescents with Cushing syndrome where the adrenal androgen excess and increased physical activity have shown to reasonably reduce protein catabolism and help in preserving muscle and bone mass. The patient was withdrawn from the drugs and was put on replacement hydrocortisone that was gradually tapered over the next few weeks and planned for surgical correction. This case highlights the fact that medical providers should be aware that a combination of anabolic steroids and glucocorticoids are still used for weight-building purposes, and these patients may present with atypical signs\/symptoms as a result of this combination of drugs.<\/jats:p>","DOI":"10.1210\/jcemcr\/luae067","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T15:52:50Z","timestamp":1713455570000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug-Induced Atypical Lipodystrophy"],"prefix":"10.1210","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-1688","authenticated-orcid":false,"given":"Priyadarshini","family":"Rajakumar","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Sri Ramachandra Medical College and Research Institute , Chennai 600116, Tamilnadu , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-5639","authenticated-orcid":false,"given":"Shriraam","family":"Mahadevan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sri Ramachandra Medical College and Research Institute , Chennai 600116, Tamilnadu , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0059-5169","authenticated-orcid":false,"given":"Adlyne Reena","family":"Asirvatham","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sri Ramachandra Medical College and Research Institute , Chennai 600116, Tamilnadu , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2741-2633","authenticated-orcid":false,"given":"Asha","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sri Ramachandra Medical College and Research Institute , Chennai 600116, Tamilnadu , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"issue":"1","key":"2024050805005010300_luae067-B1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/ijpvm.IJPVM_524_17","article-title":"Anabolic androgenic steroid abuse and their health impacts: a cross-sectional study among body builders in a city of Eastern India","volume":"10","author":"Pany","year":"2019","journal-title":"Int J Prev Med"},{"issue":"8","key":"2024050805005010300_luae067-B2","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2337\/dc12-1529","article-title":"Type 2 diabetes with partial lipodystrophy of the limbs: a new lipodystrophy phenotype","volume":"36","author":"Strickland","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"2024050805005010300_luae067-B3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3810\/psm.2001.01.316","article-title":"Androgenic-anabolic steroid-induced body changes in strength athletes","volume":"29","author":"Hartgens","year":"2001","journal-title":"Phys Sportsmed"},{"issue":"1","key":"2024050805005010300_luae067-B4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12905-020-01055-w","article-title":"A case report of Multiple Symmetric Lipomatosis (MSL) in an East Asian Female","volume":"20","author":"Jung","year":"2020","journal-title":"BMC Women's Health"},{"issue":"4","key":"2024050805005010300_luae067-B5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.numecd.2015.01.010","article-title":"Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue","volume":"25","author":"Enzi","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2024050805005010300_luae067-B6","doi-asserted-by":"crossref","first-page":"108861","DOI":"10.1016\/j.steroids.2021.108861","article-title":"Anabolic-androgenic steroids impair mitochondrial function and redox status in the heart and liver of mice","volume":"172","author":"Carteri","year":"2021","journal-title":"Steroids"},{"issue":"2","key":"2024050805005010300_luae067-B7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2008.07.033","article-title":"HIV-protease inhibitors block the enzymatic activity of purified Ste24p","volume":"374","author":"Hudon","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 2","key":"2024050805005010300_luae067-B8","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome","volume":"30","author":"Carr","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2024050805005010300_luae067-B9","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.4158\/ACCR-2019-0234","article-title":"A case of acquired generalized lipodystrophy associated with pembrolizumab in a patient with metastatic malignant melanoma","volume":"6","author":"Bedrose","year":"2020","journal-title":"AACE Clin Case Rep"},{"issue":"1","key":"2024050805005010300_luae067-B10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/biom7010016","article-title":"Alcohol, adipose tissue and lipid dysregulation","volume":"7","author":"Steiner","year":"2017","journal-title":"Biomolecules"},{"issue":"2","key":"2024050805005010300_luae067-B11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","article-title":"PCSK9 genetic variants and risk of type 2 diabetes: a Mendelian randomisation study","volume":"5","author":"Schmidt","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2024050805005010300_luae067-B12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1742-1241.2006.01128.x","article-title":"Thiazolidinediones, insulin resistance and obesity: finding a balance","volume":"60","author":"Wilding","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"15","key":"2024050805005010300_luae067-B13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","article-title":"Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","journal-title":"Drugs"},{"issue":"6","key":"2024050805005010300_luae067-B14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/endrev\/bnad016","article-title":"Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?","volume":"44","author":"Pofi","year":"2023","journal-title":"Endocr Rev"},{"issue":"1","key":"2024050805005010300_luae067-B15","first-page":"57","article-title":"Absence of cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion","volume":"87","author":"Tomlinson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024050805005010300_luae067-B16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1507\/endocrj.K08E-008","article-title":"A case of cortisol producing adrenal adenoma without phenotype of Cushing's syndrome due to impaired 11\u03b2-hydroxysteroid dehydrogenase 1activity","volume":"55","author":"Arai","year":"2008","journal-title":"Endocr J"},{"issue":"2","key":"2024050805005010300_luae067-B17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/annrheumdis-2020-218493","article-title":"Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids","volume":"80","author":"Fenton","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"2024050805005010300_luae067-B18","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.3390\/ijms22157828","article-title":"Global deletion of11\u03b2-HSD1 prevents muscle wasting associated with glucocorticoid therapy in polyarthritis","volume":"22","author":"Webster","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024050805005010300_luae067-B19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0079-6468(07)00002-1","article-title":"Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1","volume":"46","author":"Su","year":"2008","journal-title":"Prog Med Chem"},{"issue":"3","key":"2024050805005010300_luae067-B20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/1043-2760(96)00024-0","article-title":"Androgens as anabolic agents for bone","volume":"7","author":"Orwoll","year":"1996","journal-title":"Trends Endocrinol Metab"},{"issue":"1-2","key":"2024050805005010300_luae067-B21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mce.2012.08.002","article-title":"Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation","volume":"363","author":"Sirianni","year":"2012","journal-title":"Mol Cell Endocrinol"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/4\/luae067\/57446097\/luae067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/4\/luae067\/57446097\/luae067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:01:14Z","timestamp":1715144474000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luae067\/7649993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,3,22]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luae067","relation":{},"ISSN":["2755-1520"],"issn-type":[{"type":"electronic","value":"2755-1520"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,3,22]]},"article-number":"luae067"}}